News Archive

A biotechnology company spun out of Johns Hopkins has raised $20 million to fuel its quest to create a new treatment for muscular dystrophy.

A TEDCO Maryland Innovation Initiative company

The Class of 2021 consists of 52 business and community leaders from across the state.

A global pandemic, rising racial tensions and a greatly anticipated (and hotly contested) presidential election: 2020 was a year like no other in recent memory. As I reflect on the last year, I marvel at our ability as a nation and as individuals to be resilient during times of adversity — and to

The Columbia-based Maryland Technology Development Corp.’s (TEDCO) new economic relief initiative to benefit socially and economically disadvantaged and rural early-stage technology-based businesses hit hardest by the COVID-19 pandemic is now available.

TEDCO sponsored awards challenge

Featuring TEDCO's CEO and Executive Director, Troy LeMaile-Stovall

As the Director of Federal Programs, Kim is responsible for engaging with the federal government to convert scientific research into new jobs and new businesses.

Any conversation with Troy LeMaile-Stovall will always be punctuated by action words that lead to a more inclusive and productive environment.

Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced it submitted an Investigational New Drug (IND) application with the U.S. Food and Drug

Maryland Technology Development Corp. (TEDCO) will distribute $5 million to local startups that have been hit especially hard by the Covid-19 pandemic, namely rural businesses or those led by socially and economically disadvantaged founders.

The agency is administering a state relief fund for entrepreneurs who are disadvantaged, or based in rural areas. Expect the funds to be available in February 2021.